CD33 and neoplasm: Finally, the specificity of CD33-CAR NK cells was tested against CD33+ tumor cells: the RS4;11 tumor cell line was killed by CD33-CAR NK cells with high efficiency when expressing CD33, whereas a variant that did not express CD33 (GFP+RS4;11) was not recognized (Figure 1F).